Miconazole warnings and precautions: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Miconazole}} {{CMG}}; {{AE}} {{AZ}} ==Warnings and Precautions== ===Hypersensitivity=== Allergic reactions, including anaphylactic reactions and hypersens...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 7: | Line 7: | ||
===Hypersensitivity=== | ===Hypersensitivity=== | ||
Allergic reactions, including [[anaphylactic]] reactions and [[hypersensitivity]], have been reported with the administration of miconazole products, including | Allergic reactions, including [[anaphylactic]] reactions and [[hypersensitivity]], have been reported with the administration of miconazole products, including ORAVIG®. | ||
Discontinue ORAVIG® '''immediately''' at the first sign of [[hypersensitivity]]. | |||
There is '''no information''' regarding '''cross-hypersensitivity''' between miconazole and other azole antifungal agents. | There is '''no information''' regarding '''cross-hypersensitivity''' between miconazole and other azole antifungal agents. | ||
Monitor patients with a history of hypersensitivity to azoles.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ORAVIG (MICONAZOLE) TABLET [PRAELIA PHARMACEUTICALS INC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef3b205e-8526-48a0-afce-ddcef865d907 | publisher = | date = | accessdate = }}</ref> | Monitor patients with a history of hypersensitivity to azoles.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ORAVIG (MICONAZOLE) TABLET [PRAELIA PHARMACEUTICALS INC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef3b205e-8526-48a0-afce-ddcef865d907 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== |
Latest revision as of 09:00, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Warnings and Precautions
Hypersensitivity
Allergic reactions, including anaphylactic reactions and hypersensitivity, have been reported with the administration of miconazole products, including ORAVIG®.
Discontinue ORAVIG® immediately at the first sign of hypersensitivity.
There is no information regarding cross-hypersensitivity between miconazole and other azole antifungal agents.
Monitor patients with a history of hypersensitivity to azoles.[1]
References
Adapted from the FDA Package Insert.